Literature DB >> 29731092

New Left Lobe Transplantation Procedure with Caval Reconstruction Using an Inverted Composite Graft for Chronic Budd-Chiari Syndrome in Living-Donor Liver Transplantation-A Case Report.

T Yagi1, K Takagi2, R Yoshida2, Y Umeda2, D Nobuoka2, T Kuise2, T Fujiwara2, A Takaki2.   

Abstract

When the Budd-Chiari syndrome (BCS) lesion extends to the inferior vena cava (IVC) or the orifices of the hepatic vein, the thickened IVC and/or hepatic vein wall must be removed and IVC reconstruction is required in living-donor liver transplantation (LDLT). In various reports about IVC resection in LDLT for BCS, there are none about left lobe liver transplantation with reconstruction of the retrohepatic IVC (rhIVC). To overcome removal and reconstruction of the rhIVC in LDLT for BCS, we introduced a composite IVC graft that is applicable to both right and left lobe partial liver grafts for LDLT for BCS. Pathogenic IVC was removed together with the native liver between the lower edge of the right atrium and 5 cm above the renal vein junction with the use of venovenous bypass. The e-polytetrafluoroethylene graft was anastomosed to the suprarenal intact IVC. Then the native part was detached at the level of just above the renal junction. The composite graft was inverted and a half rim of the native part of the graft was anastomosed to the posterior wall of the right atrium. Next, the common venous orifice of the left lobe graft was anastomosed to the wall defect which was composed of the anterior wall of the right atrium and the distal end of the native part of the composite graft. In conclusion, our inverted composite graft technique will overcome the weak points of LDLT for BCS, such as incomplete removal of the pathogenic caval wall and reconstruction of the rhIVC.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29731092     DOI: 10.1016/j.transproceed.2017.11.078

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

1.  Liver Transplantation and Budd-Chiari Syndrome: When the Cause Becomes the Solution.

Authors:  Nikolaos Garmpis; Christos Damaskos; Dionysios Prevezanos; Anna Garmpi; Vasiliki E Georgakopoulou; Efstathios A Antoniou; Gregory Kouraklis; Dimitrios Dimitroulis
Journal:  Maedica (Bucur)       Date:  2022-06

2.  Left trisectionectomy and supra-hepatic caval reconstruction with vascular prosthesis for chronic Budd-Chiari syndrome caused by hepatic alveolar echinococcosis.

Authors:  Bo Ran; Tie-Min Jiang; Aimaiti Yasen; Abudusalamu Aini; Qiang Guo; Rui-Qing Zhang; Ying-Mei Shao; Hao Wen; Aji Tuerganaili
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

3.  Living-donor liver transplantation in Budd-Chiari syndrome with inferior vena cava complete thrombosis: A case report and review of the literature.

Authors:  Vinicius Rocha-Santos; Daniel Reis Waisberg; Rafael Soares Pinheiro; Lucas Souto Nacif; Rubens Macedo Arantes; Liliana Ducatti; Rodrigo Bronze Martino; Luciana Bertocco Haddad; Flavio Henrique Galvao; Wellington Andraus; Luiz Augusto Carneiro-D'Alburquerque
Journal:  World J Hepatol       Date:  2021-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.